Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6A31
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,853
Award facts
- Contract value 100% obligated
- $43,853.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $43,853.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 27, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors, with final completion scheduled for January 28, 2026. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion global pharmaceutical supply vehicle that enables the company to deliver a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare systems worldwide through December 2026. The parent organization, Cencora, Inc. (doing business as AmerisourceBergen), holds the overarching DLA IDC valued at up to $999.99 billion through December 2031.
Repatha is a PCSK9 inhibitor used in the treatment of high cholesterol and cardiovascular disease, indicating this delivery order supports the pharmaceutical needs of military treatment facilities and defense healthcare operations. The firm fixed-price delivery order structure and competitive award process reflect AmerisourceBergen's established capability to efficiently fulfill federal pharmaceutical procurement requirements, consistent with its role as a critical vendor in the federal medical supply chain serving military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6A31?
SPE2DR26F6A31 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F6A31 worth?
The government has obligated $43,853 on SPE2DR26F6A31.
Is contract SPE2DR26F6A31 an order under another contract?
Yes. SPE2DR26F6A31 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F6A31 competed?
The extent of competition for SPE2DR26F6A31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award